An upper bound on one-to-one exposure to infectious human respiratory particles.
Gholamhossein BagheriBirte ThiedeBardia HejaziOliver SchlenczekEberhard BodenschatzPublished in: Proceedings of the National Academy of Sciences of the United States of America (2021)
There is ample evidence that masking and social distancing are effective in reducing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. However, due to the complexity of airborne disease transmission, it is difficult to quantify their effectiveness, especially in the case of one-to-one exposure. Here, we introduce the concept of an upper bound for one-to-one exposure to infectious human respiratory particles and apply it to SARS-CoV-2. To calculate exposure and infection risk, we use a comprehensive database on respiratory particle size distribution; exhalation flow physics; leakage from face masks of various types and fits measured on human subjects; consideration of ambient particle shrinkage due to evaporation; and rehydration, inhalability, and deposition in the susceptible airways. We find, for a typical SARS-CoV-2 viral load and infectious dose, that social distancing alone, even at 3.0 m between two speaking individuals, leads to an upper bound of 90% for risk of infection after a few minutes. If only the susceptible wears a face mask with infectious speaking at a distance of 1.5 m, the upper bound drops very significantly; that is, with a surgical mask, the upper bound reaches 90% after 30 min, and, with an FFP2 mask, it remains at about 20% even after 1 h. When both wear a surgical mask, while the infectious is speaking, the very conservative upper bound remains below 30% after 1 h, but, when both wear a well-fitting FFP2 mask, it is 0.4%. We conclude that wearing appropriate masks in the community provides excellent protection for others and oneself, and makes social distancing less important.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- endothelial cells
- healthcare
- mental health
- induced pluripotent stem cells
- randomized controlled trial
- pluripotent stem cells
- systematic review
- positive airway pressure
- particulate matter
- coronavirus disease
- cystic fibrosis
- emergency department
- respiratory tract
- electronic health record